Director Dealing
The Company announces that Dr Jim Millen, Chief Executive Officer of Physiomics, has transferred, for no consideration, 242,287 ordinary shares of 0.4p each in the Company (“Ordinary Shares”) from a brokerage account with James Brearley & Sons Limited to an account with Interactive Investors. The Ordinary Shares remain beneficially owned by Dr Millen.
Dr Millen’s holding in the Company therefore remains 1,384,393 Ordinary Shares, representing approximately 1.42 per cent. of the Company’s issued share capital.
Enquiries:
Physiomics plc
Dr Jim Millen, CEO
+44 (0)1865 784 980
Hybridan LLP (broker)
Claire Louise Noyce
+44 (0) 203 764 2341
Strand Hanson Ltd (NOMAD)
James Dance & James Bellman
+44 (0)20 7409 3494
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM
| 1 | Details of the person discharging managerial responsibilities/person closely associated | |||||
| a) | Name | James Millen | ||||
| 2 | Reason for the notification | |||||
| a) | Position/status | Director, CEO | ||||
| b) | Initial notification/ Amendment | Initial notification | ||||
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
| a) | Name | Physiomics plc | ||||
| b) | LEI | 213800A71DSZ6ABMTQ91 | ||||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
| a) | Description of the financial instrument, type of instrument
Identification code |
Ordinary share
GB00BDR6W943 |
||||
| b) | Nature of the transaction | Transfer of Ordinary Shares | ||||
| c) | Price(s) and volume(s) |
|
||||
| d) | Aggregated information
– Aggregated volume – Price |
242,287 Nil |
||||
| e) | Date of the transaction | 21 May 2021 | ||||
| f) | Place of the transaction | XLON, AIM | ||||